ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
29.24
-0.27 (-0.91%)
Feb 25, 2026, 4:00 PM EST - Market closed
ARKG Holdings Information
ARKG is an equity ETF with a total of 35 individual holdings. The top holdings are CRISPR Therapeutics AG stock at 9.54%, Tempus AI at 8.96%, Twist Bioscience at 8.27%, Beam Therapeutics at 5.90%, and Personalis at 5.60%.
Total Holdings
35
Top 10 Percentage
59.27%
Asset Class
Equity
ETF Category
Health
Assets
1.22B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | 9.54% |
| 2 | TEM | Tempus AI, Inc. | 8.96% |
| 3 | TWST | Twist Bioscience Corporation | 8.27% |
| 4 | BEAM | Beam Therapeutics Inc. | 5.90% |
| 5 | PSNL | Personalis, Inc. | 5.60% |
| 6 | TXG | 10x Genomics, Inc. | 5.10% |
| 7 | GH | Guardant Health, Inc. | 4.28% |
| 8 | NTRA | Natera, Inc. | 4.02% |
| 9 | ILMN | Illumina, Inc. | 3.96% |
| 10 | RXRX | Recursion Pharmaceuticals, Inc. | 3.64% |
| 11 | CDNA | CareDx, Inc. | 3.32% |
| 12 | NTLA | Intellia Therapeutics, Inc. | 3.32% |
| 13 | VCYT | Veracyte, Inc. | 3.18% |
| 14 | ADPT | Adaptive Biotechnologies Corporation | 2.80% |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 2.79% |
| 16 | ABSI | Absci Corporation | 2.64% |
| 17 | NRIX | Nurix Therapeutics, Inc. | 2.07% |
| 18 | SDGR | Schrödinger, Inc. | 1.94% |
| 19 | CMPS | COMPASS Pathways plc | 1.89% |
| 20 | WGS | GeneDx Holdings Corp. | 1.78% |
| 21 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.74% |
| 22 | PRME | Prime Medicine, Inc. | 1.55% |
| 23 | PACB | Pacific Biosciences of California, Inc. | 1.50% |
| 24 | BFLY | Butterfly Network, Inc. | 1.49% |
| 25 | AMGN | Amgen Inc. | 1.40% |
As of Feb 25, 2026